Logo

RCMT

RCM Technologies, Inc.

RCMT

RCM Technologies, Inc. • NASDAQ
$19.58 ▼ -0.51% (-0.10)
Market Cap $145.10 M
52w High $28.27
52w Low $13.18
Dividend Yield 0%
P/E 11.45
Volume 33.65K
Outstanding Shares 7.41M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $70.289M ▼ $14.933M ▼ $2.259M ▼ 3.214% ▼ $0.3 ▼ $3.863M ▼
Q2-2025 $78.166M ▼ $15.676M ▲ $3.785M ▼ 4.842% ▼ $0.5 ▼ $6.723M ▼
Q1-2025 $84.473M ▲ $15.395M ▲ $4.186M ▲ 4.955% ▲ $0.55 ▲ $6.96M ▼
Q4-2024 $76.912M ▲ $15.284M ▲ $2.867M ▲ 3.728% ▼ $0.38 ▲ $7.387M ▲
Q3-2024 $60.365M $13.456M $2.746M 4.549% $0.35 $4.651M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.309M ▼ $129.815M ▼ $88.437M ▼ $41.378M ▲
Q2-2025 $5.472M ▲ $135.586M ▲ $97.8M ▲ $37.786M ▲
Q1-2025 $5.181M ▲ $120.992M ▼ $86.392M ▼ $34.6M ▲
Q4-2024 $4.729M ▲ $132.077M ▲ $98.593M ▲ $33.484M ▲
Q3-2024 $3.156M $125.545M $95.505M $30.04M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $2.259M ▼ $-1.262M ▲ $-498K ▼ $-2.379M ▼ $-4.163M ▼ $-1.76M ▲
Q2-2025 $3.785M ▼ $-7.878M ▼ $-473K ▼ $8.491M ▲ $291K ▼ $-8.351M ▼
Q1-2025 $4.186M ▲ $16.66M ▲ $-427K ▲ $-15.583M ▼ $452K ▼ $16.233M ▲
Q4-2024 $2.867M ▲ $-1.637M ▲ $-983K ▼ $4.307M ▼ $1.573M ▲ $-2.62M ▲
Q3-2024 $2.746M $-4.344M $-522K $4.375M $-324K $-4.866M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Engineering Services
Engineering Services
 $50.00M ▲$30.00M ▼$30.00M ▲$30.00M ▲
Health Care
Health Care
 $80.00M ▲$40.00M ▼$40.00M ▲$30.00M ▼
Technology Service
Technology Service
 $20.00M ▲$10.00M ▼$10.00M ▲$10.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown meaningfully from pre‑pandemic levels and has generally held in a healthy range over the last few years, though it appears to have plateaued more recently. Profitability has improved a lot since 2020, moving from losses to consistent operating and net income. That said, earnings per share peaked a couple of years ago and have eased a bit since, suggesting the business is solidly profitable but not currently in a strong acceleration phase. Overall, the income statement reflects a mature, niche services company with decent margins and a relatively stable earnings base, but not a clear trend of rapid growth in the most recent period.

Balance Sheet

Balance Sheet The balance sheet looks fairly lean and asset‑light, which is typical for a services and consulting model. Total assets have crept up over time, and equity has gradually increased, pointing to retained profitability. Debt is present but not dominant, implying some leverage but not an obviously stretched financial position. Cash on hand is modest, so the company likely relies more on ongoing cash generation and credit lines than on a large cash buffer. In short, the balance sheet appears efficient but not overly conservative, with a manageable level of financial risk as long as earnings remain stable.

Cash Flow

Cash Flow Available data shows that in at least one recent year the company generated solid operating cash flow that closely matched its reported profits, a good sign that earnings are backed by real cash. Capital spending appears very low, consistent with an asset‑light consulting and services business, which supports strong free cash flow when revenues are steady. However, the lack of a longer cash‑flow history in the data makes it harder to judge how resilient cash generation is across cycles or in weaker demand environments.

Competitive Edge

Competitive Edge RCM operates in specialized, regulated niches—such as aerospace and defense, energy, life sciences, and healthcare staffing—where deep domain expertise and compliance know‑how matter more than sheer scale. The firm’s long‑standing client relationships and embedded positions in key accounts create switching costs and recurring work, which strengthens its competitive position. Its diversified mix across engineering, healthcare, and IT solutions helps cushion downturns in any one segment and opens opportunities for cross‑selling. On the flip side, the company competes against much larger consulting and staffing firms, so its edge depends heavily on maintaining its specialist reputation, service quality, and close customer ties rather than price or brand alone.

Innovation and R&D

Innovation and R&D Innovation at RCM is more about applied technology and proprietary tools than about heavy, lab‑style R&D spending. The company has developed its own platforms like the P6D tool for advanced engineering and project modeling, and it uses model‑based systems engineering in aerospace and defense—both of which can create meaningful differentiation in winning and executing complex projects. Across life sciences and IT, RCM is leaning into artificial intelligence and machine learning, focusing on validated, regulatory‑compliant solutions and data‑driven services. Its large, curated healthcare talent database also acts as a kind of intangible asset. Future innovation seems directed toward expanding AI‑enabled offerings, life sciences capabilities, and strategic acquisitions that add new technologies or specialty skills.

Summary

RCM Technologies has transformed itself from a loss‑making business in 2020 into a consistently profitable, specialized services company. Revenue and margins are far stronger than they were a few years ago, though recent results suggest more of a steady state than a high‑growth phase. The balance sheet is relatively lean with manageable debt, modest cash, and slowly rising equity, which should be adequate if earnings remain stable. Cash generation appears strong relative to capital needs, reflecting an asset‑light model. Competitively, RCM leans on niche expertise, long client relationships, and proprietary tools rather than scale, and it is actively weaving AI and advanced engineering methods into its offerings. Key watch points include: whether the company can reignite faster revenue growth, how effectively it monetizes its proprietary and AI‑driven solutions, and its ability to maintain margins and cash flow in a competitive, cyclical set of end markets.

NEWS

November 14, 2025 · 5:05 PM UTC

Everyday People Financial Reports Record Revenue Growth of 51% in RCM Segment and Expands AnyDay Tip Payments Program

Read more

November 5, 2025 · 4:30 PM UTC

RCM Technologies, Inc. Announces Third Quarter Results

Read more

September 5, 2025 · 12:00 PM UTC

Cosentus Invests in Accreda Healthcare Management — An Anesthesia-Exclusive RCM Provider

Read more